Increased heart rate with sleep disordered breathing in hypertrophic cardiomyopathy

Current guidelines recommend medications with rate control properties for symptomatic patients with hypertrophic cardiomyopathy (HCM) based on the rationale that lowering heart rate (HR) improves their symptoms. Whether sleep disordered breathing (SDB) is associated with increased HR in HCM patients...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of cardiology 2021-01, Vol.323, p.155-160
Hauptverfasser: Konecny, Tomas, Khoo, Michael, Covassin, Naima, Edelhofer, Paul, Bukartyk, Jan, Park, Jae Yoon, Venkataraman, Shreyas, Karim, Shahid, Chahal, Anwar, Kara, Tomas, Orban, Marek, Ludka, Ondrej, Kautzner, Josef, Ommen, Steve R., Somers, Virend K.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 160
container_issue
container_start_page 155
container_title International journal of cardiology
container_volume 323
creator Konecny, Tomas
Khoo, Michael
Covassin, Naima
Edelhofer, Paul
Bukartyk, Jan
Park, Jae Yoon
Venkataraman, Shreyas
Karim, Shahid
Chahal, Anwar
Kara, Tomas
Orban, Marek
Ludka, Ondrej
Kautzner, Josef
Ommen, Steve R.
Somers, Virend K.
description Current guidelines recommend medications with rate control properties for symptomatic patients with hypertrophic cardiomyopathy (HCM) based on the rationale that lowering heart rate (HR) improves their symptoms. Whether sleep disordered breathing (SDB) is associated with increased HR in HCM patients is not known. We diagnosed uncontrolled SDB (oxygen desaturation index ≥5) in consecutive echocardiographically confirmed HCM patients seen at Mayo Clinic, Rochester, and analyzed their HR as recorded by a 24-h Holter monitor. We compared mean, minimum, maximum HR between those with vs without SDB. In a pilot subanalysis of HCM patients with SDB who also underwent subsequent diagnostic polysomnography (PSG), we analyzed RR interval changes coinciding with obstructive sleep apnea and hypopnea episodes. Of the 230 HCM patients included in this study (age 54 ± 16 years; 138 male; LVOT pressure gradient at rest 45 ± 39 mmHg), 115 (50%) patients had SDB. HCM patients with SDB were recorded to have higher mean HR (71 vs. 67 bpm; p = .002, adjusted p = .001), and this difference was most pronounced during night hours of 10 PM to 5 AM (61 vs. 67 bpm; p 
doi_str_mv 10.1016/j.ijcard.2020.08.020
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10426808</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0167527320335476</els_id><sourcerecordid>2434757060</sourcerecordid><originalsourceid>FETCH-LOGICAL-c464t-9cc7e8d101844982c3361304c8c45e26abfdc67f8dde366d8e366693c7b429fe3</originalsourceid><addsrcrecordid>eNp9kUFP3DAQha0KVLa0_6CqcuSS4Nhe27lQVahQJKQegLPlHU-IV9k4tb2g_ff1aimCSy_zDvPNm7EfIV9b2rS0lefrxq_BRtcwymhDdVPkA1m0Wom6VUtxRBYFU_WSKX5CPqW0ppSKrtMfyQlnqtOSqQW5u5kgok3oqgFtzFW0Gatnn4cqjYhz5XwK0WEswKqAefDTY-WnatjNGHMM8-Ch2t_hw2YX5gLsPpPj3o4Jv7zoKXm4-nl_-au-_X19c_njtgYhRa47AIXalcdoITrNgHPZcipAg1gik3bVO5Cq184hl9LpfZUdB7USrOuRn5LvB995u9qgA5xytKOZo9_YuDPBevO-M_nBPIYn01LBpKa6OJy9OMTwZ4spm41PgONoJwzbZJjgQi0VlbSg4oBCDClF7F_3tNTsAzFrcwjE7AMxVJsiZezb2xtfh_4lUICLA4Dlp548RpPA4wTofETIxgX__w1_AYpXoIg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2434757060</pqid></control><display><type>article</type><title>Increased heart rate with sleep disordered breathing in hypertrophic cardiomyopathy</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Konecny, Tomas ; Khoo, Michael ; Covassin, Naima ; Edelhofer, Paul ; Bukartyk, Jan ; Park, Jae Yoon ; Venkataraman, Shreyas ; Karim, Shahid ; Chahal, Anwar ; Kara, Tomas ; Orban, Marek ; Ludka, Ondrej ; Kautzner, Josef ; Ommen, Steve R. ; Somers, Virend K.</creator><creatorcontrib>Konecny, Tomas ; Khoo, Michael ; Covassin, Naima ; Edelhofer, Paul ; Bukartyk, Jan ; Park, Jae Yoon ; Venkataraman, Shreyas ; Karim, Shahid ; Chahal, Anwar ; Kara, Tomas ; Orban, Marek ; Ludka, Ondrej ; Kautzner, Josef ; Ommen, Steve R. ; Somers, Virend K.</creatorcontrib><description>Current guidelines recommend medications with rate control properties for symptomatic patients with hypertrophic cardiomyopathy (HCM) based on the rationale that lowering heart rate (HR) improves their symptoms. Whether sleep disordered breathing (SDB) is associated with increased HR in HCM patients is not known. We diagnosed uncontrolled SDB (oxygen desaturation index ≥5) in consecutive echocardiographically confirmed HCM patients seen at Mayo Clinic, Rochester, and analyzed their HR as recorded by a 24-h Holter monitor. We compared mean, minimum, maximum HR between those with vs without SDB. In a pilot subanalysis of HCM patients with SDB who also underwent subsequent diagnostic polysomnography (PSG), we analyzed RR interval changes coinciding with obstructive sleep apnea and hypopnea episodes. Of the 230 HCM patients included in this study (age 54 ± 16 years; 138 male; LVOT pressure gradient at rest 45 ± 39 mmHg), 115 (50%) patients had SDB. HCM patients with SDB were recorded to have higher mean HR (71 vs. 67 bpm; p = .002, adjusted p = .001), and this difference was most pronounced during night hours of 10 PM to 5 AM (61 vs. 67 bpm; p &lt; .001). In the pilot analysis of the available PSG data, the release of obstructive sleep apneas and hypopneas coincided with fluctuation of HR. SDB is independently associated with higher mean HR in patients with HCM, and this difference is most significant during sleep. Treatment of SDB, which is readily available, should be tested as a complementary modality to the currently recommended pharmacotherapy aimed at lowering HR in patients with symptomatic HCM. •Hypertrophic cardiomyopathy patients with sleep apnea have higher mean heart rate•This difference is most pronounced during night-time hours.•Further studies could explore whether sleep apnea treatment could complement rate-control medications in symptomatic patients.</description><identifier>ISSN: 0167-5273</identifier><identifier>EISSN: 1874-1754</identifier><identifier>DOI: 10.1016/j.ijcard.2020.08.020</identifier><identifier>PMID: 32798627</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Adult ; Aged ; Autonomic nervous system ; Cardiomyopathy, Hypertrophic - complications ; Cardiomyopathy, Hypertrophic - diagnostic imaging ; Heart Rate ; Humans ; Hypertrophic cardiomyopathy ; Male ; Middle Aged ; Polysomnography ; Sleep apnea ; Sleep Apnea Syndromes - diagnosis ; Sleep Apnea Syndromes - epidemiology ; Sleep Apnea, Obstructive - diagnosis ; Sleep Apnea, Obstructive - epidemiology ; Sleep disordered breathing</subject><ispartof>International journal of cardiology, 2021-01, Vol.323, p.155-160</ispartof><rights>2020</rights><rights>Copyright © 2020. Published by Elsevier B.V.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c464t-9cc7e8d101844982c3361304c8c45e26abfdc67f8dde366d8e366693c7b429fe3</citedby><cites>FETCH-LOGICAL-c464t-9cc7e8d101844982c3361304c8c45e26abfdc67f8dde366d8e366693c7b429fe3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ijcard.2020.08.020$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3536,27903,27904,45974</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32798627$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Konecny, Tomas</creatorcontrib><creatorcontrib>Khoo, Michael</creatorcontrib><creatorcontrib>Covassin, Naima</creatorcontrib><creatorcontrib>Edelhofer, Paul</creatorcontrib><creatorcontrib>Bukartyk, Jan</creatorcontrib><creatorcontrib>Park, Jae Yoon</creatorcontrib><creatorcontrib>Venkataraman, Shreyas</creatorcontrib><creatorcontrib>Karim, Shahid</creatorcontrib><creatorcontrib>Chahal, Anwar</creatorcontrib><creatorcontrib>Kara, Tomas</creatorcontrib><creatorcontrib>Orban, Marek</creatorcontrib><creatorcontrib>Ludka, Ondrej</creatorcontrib><creatorcontrib>Kautzner, Josef</creatorcontrib><creatorcontrib>Ommen, Steve R.</creatorcontrib><creatorcontrib>Somers, Virend K.</creatorcontrib><title>Increased heart rate with sleep disordered breathing in hypertrophic cardiomyopathy</title><title>International journal of cardiology</title><addtitle>Int J Cardiol</addtitle><description>Current guidelines recommend medications with rate control properties for symptomatic patients with hypertrophic cardiomyopathy (HCM) based on the rationale that lowering heart rate (HR) improves their symptoms. Whether sleep disordered breathing (SDB) is associated with increased HR in HCM patients is not known. We diagnosed uncontrolled SDB (oxygen desaturation index ≥5) in consecutive echocardiographically confirmed HCM patients seen at Mayo Clinic, Rochester, and analyzed their HR as recorded by a 24-h Holter monitor. We compared mean, minimum, maximum HR between those with vs without SDB. In a pilot subanalysis of HCM patients with SDB who also underwent subsequent diagnostic polysomnography (PSG), we analyzed RR interval changes coinciding with obstructive sleep apnea and hypopnea episodes. Of the 230 HCM patients included in this study (age 54 ± 16 years; 138 male; LVOT pressure gradient at rest 45 ± 39 mmHg), 115 (50%) patients had SDB. HCM patients with SDB were recorded to have higher mean HR (71 vs. 67 bpm; p = .002, adjusted p = .001), and this difference was most pronounced during night hours of 10 PM to 5 AM (61 vs. 67 bpm; p &lt; .001). In the pilot analysis of the available PSG data, the release of obstructive sleep apneas and hypopneas coincided with fluctuation of HR. SDB is independently associated with higher mean HR in patients with HCM, and this difference is most significant during sleep. Treatment of SDB, which is readily available, should be tested as a complementary modality to the currently recommended pharmacotherapy aimed at lowering HR in patients with symptomatic HCM. •Hypertrophic cardiomyopathy patients with sleep apnea have higher mean heart rate•This difference is most pronounced during night-time hours.•Further studies could explore whether sleep apnea treatment could complement rate-control medications in symptomatic patients.</description><subject>Adult</subject><subject>Aged</subject><subject>Autonomic nervous system</subject><subject>Cardiomyopathy, Hypertrophic - complications</subject><subject>Cardiomyopathy, Hypertrophic - diagnostic imaging</subject><subject>Heart Rate</subject><subject>Humans</subject><subject>Hypertrophic cardiomyopathy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Polysomnography</subject><subject>Sleep apnea</subject><subject>Sleep Apnea Syndromes - diagnosis</subject><subject>Sleep Apnea Syndromes - epidemiology</subject><subject>Sleep Apnea, Obstructive - diagnosis</subject><subject>Sleep Apnea, Obstructive - epidemiology</subject><subject>Sleep disordered breathing</subject><issn>0167-5273</issn><issn>1874-1754</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUFP3DAQha0KVLa0_6CqcuSS4Nhe27lQVahQJKQegLPlHU-IV9k4tb2g_ff1aimCSy_zDvPNm7EfIV9b2rS0lefrxq_BRtcwymhDdVPkA1m0Wom6VUtxRBYFU_WSKX5CPqW0ppSKrtMfyQlnqtOSqQW5u5kgok3oqgFtzFW0Gatnn4cqjYhz5XwK0WEswKqAefDTY-WnatjNGHMM8-Ch2t_hw2YX5gLsPpPj3o4Jv7zoKXm4-nl_-au-_X19c_njtgYhRa47AIXalcdoITrNgHPZcipAg1gik3bVO5Cq184hl9LpfZUdB7USrOuRn5LvB995u9qgA5xytKOZo9_YuDPBevO-M_nBPIYn01LBpKa6OJy9OMTwZ4spm41PgONoJwzbZJjgQi0VlbSg4oBCDClF7F_3tNTsAzFrcwjE7AMxVJsiZezb2xtfh_4lUICLA4Dlp548RpPA4wTofETIxgX__w1_AYpXoIg</recordid><startdate>20210115</startdate><enddate>20210115</enddate><creator>Konecny, Tomas</creator><creator>Khoo, Michael</creator><creator>Covassin, Naima</creator><creator>Edelhofer, Paul</creator><creator>Bukartyk, Jan</creator><creator>Park, Jae Yoon</creator><creator>Venkataraman, Shreyas</creator><creator>Karim, Shahid</creator><creator>Chahal, Anwar</creator><creator>Kara, Tomas</creator><creator>Orban, Marek</creator><creator>Ludka, Ondrej</creator><creator>Kautzner, Josef</creator><creator>Ommen, Steve R.</creator><creator>Somers, Virend K.</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20210115</creationdate><title>Increased heart rate with sleep disordered breathing in hypertrophic cardiomyopathy</title><author>Konecny, Tomas ; Khoo, Michael ; Covassin, Naima ; Edelhofer, Paul ; Bukartyk, Jan ; Park, Jae Yoon ; Venkataraman, Shreyas ; Karim, Shahid ; Chahal, Anwar ; Kara, Tomas ; Orban, Marek ; Ludka, Ondrej ; Kautzner, Josef ; Ommen, Steve R. ; Somers, Virend K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c464t-9cc7e8d101844982c3361304c8c45e26abfdc67f8dde366d8e366693c7b429fe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Autonomic nervous system</topic><topic>Cardiomyopathy, Hypertrophic - complications</topic><topic>Cardiomyopathy, Hypertrophic - diagnostic imaging</topic><topic>Heart Rate</topic><topic>Humans</topic><topic>Hypertrophic cardiomyopathy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Polysomnography</topic><topic>Sleep apnea</topic><topic>Sleep Apnea Syndromes - diagnosis</topic><topic>Sleep Apnea Syndromes - epidemiology</topic><topic>Sleep Apnea, Obstructive - diagnosis</topic><topic>Sleep Apnea, Obstructive - epidemiology</topic><topic>Sleep disordered breathing</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Konecny, Tomas</creatorcontrib><creatorcontrib>Khoo, Michael</creatorcontrib><creatorcontrib>Covassin, Naima</creatorcontrib><creatorcontrib>Edelhofer, Paul</creatorcontrib><creatorcontrib>Bukartyk, Jan</creatorcontrib><creatorcontrib>Park, Jae Yoon</creatorcontrib><creatorcontrib>Venkataraman, Shreyas</creatorcontrib><creatorcontrib>Karim, Shahid</creatorcontrib><creatorcontrib>Chahal, Anwar</creatorcontrib><creatorcontrib>Kara, Tomas</creatorcontrib><creatorcontrib>Orban, Marek</creatorcontrib><creatorcontrib>Ludka, Ondrej</creatorcontrib><creatorcontrib>Kautzner, Josef</creatorcontrib><creatorcontrib>Ommen, Steve R.</creatorcontrib><creatorcontrib>Somers, Virend K.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Konecny, Tomas</au><au>Khoo, Michael</au><au>Covassin, Naima</au><au>Edelhofer, Paul</au><au>Bukartyk, Jan</au><au>Park, Jae Yoon</au><au>Venkataraman, Shreyas</au><au>Karim, Shahid</au><au>Chahal, Anwar</au><au>Kara, Tomas</au><au>Orban, Marek</au><au>Ludka, Ondrej</au><au>Kautzner, Josef</au><au>Ommen, Steve R.</au><au>Somers, Virend K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Increased heart rate with sleep disordered breathing in hypertrophic cardiomyopathy</atitle><jtitle>International journal of cardiology</jtitle><addtitle>Int J Cardiol</addtitle><date>2021-01-15</date><risdate>2021</risdate><volume>323</volume><spage>155</spage><epage>160</epage><pages>155-160</pages><issn>0167-5273</issn><eissn>1874-1754</eissn><abstract>Current guidelines recommend medications with rate control properties for symptomatic patients with hypertrophic cardiomyopathy (HCM) based on the rationale that lowering heart rate (HR) improves their symptoms. Whether sleep disordered breathing (SDB) is associated with increased HR in HCM patients is not known. We diagnosed uncontrolled SDB (oxygen desaturation index ≥5) in consecutive echocardiographically confirmed HCM patients seen at Mayo Clinic, Rochester, and analyzed their HR as recorded by a 24-h Holter monitor. We compared mean, minimum, maximum HR between those with vs without SDB. In a pilot subanalysis of HCM patients with SDB who also underwent subsequent diagnostic polysomnography (PSG), we analyzed RR interval changes coinciding with obstructive sleep apnea and hypopnea episodes. Of the 230 HCM patients included in this study (age 54 ± 16 years; 138 male; LVOT pressure gradient at rest 45 ± 39 mmHg), 115 (50%) patients had SDB. HCM patients with SDB were recorded to have higher mean HR (71 vs. 67 bpm; p = .002, adjusted p = .001), and this difference was most pronounced during night hours of 10 PM to 5 AM (61 vs. 67 bpm; p &lt; .001). In the pilot analysis of the available PSG data, the release of obstructive sleep apneas and hypopneas coincided with fluctuation of HR. SDB is independently associated with higher mean HR in patients with HCM, and this difference is most significant during sleep. Treatment of SDB, which is readily available, should be tested as a complementary modality to the currently recommended pharmacotherapy aimed at lowering HR in patients with symptomatic HCM. •Hypertrophic cardiomyopathy patients with sleep apnea have higher mean heart rate•This difference is most pronounced during night-time hours.•Further studies could explore whether sleep apnea treatment could complement rate-control medications in symptomatic patients.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>32798627</pmid><doi>10.1016/j.ijcard.2020.08.020</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0167-5273
ispartof International journal of cardiology, 2021-01, Vol.323, p.155-160
issn 0167-5273
1874-1754
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10426808
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adult
Aged
Autonomic nervous system
Cardiomyopathy, Hypertrophic - complications
Cardiomyopathy, Hypertrophic - diagnostic imaging
Heart Rate
Humans
Hypertrophic cardiomyopathy
Male
Middle Aged
Polysomnography
Sleep apnea
Sleep Apnea Syndromes - diagnosis
Sleep Apnea Syndromes - epidemiology
Sleep Apnea, Obstructive - diagnosis
Sleep Apnea, Obstructive - epidemiology
Sleep disordered breathing
title Increased heart rate with sleep disordered breathing in hypertrophic cardiomyopathy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T13%3A16%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Increased%20heart%20rate%20with%20sleep%20disordered%20breathing%20in%20hypertrophic%20cardiomyopathy&rft.jtitle=International%20journal%20of%20cardiology&rft.au=Konecny,%20Tomas&rft.date=2021-01-15&rft.volume=323&rft.spage=155&rft.epage=160&rft.pages=155-160&rft.issn=0167-5273&rft.eissn=1874-1754&rft_id=info:doi/10.1016/j.ijcard.2020.08.020&rft_dat=%3Cproquest_pubme%3E2434757060%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2434757060&rft_id=info:pmid/32798627&rft_els_id=S0167527320335476&rfr_iscdi=true